Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra
- 1 February 1987
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 403 (1) , 43-51
- https://doi.org/10.1016/0006-8993(87)90120-x
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP + Binds to NeuromelaninScience, 1986
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- Progress in Parkinson's DiseaseNew England Journal of Medicine, 1984
- Etiology of Parkinson’s Disease: A Research StrategyCanadian Journal of Neurological Sciences, 1984
- AETIOLOGY OF PARKINSON'S DISEASEThe Lancet, 1983
- The effect of age on the activity and molecular properties of human brain monoamine oxidaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1980
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- Long-Term Changes in Dopaminergic Innervation of Caudate Nucleus After Continuous Amphetamine AdministrationScience, 1978
- Two methods for selective silver impregnation of degenerating axons and their synaptic endings in the central nervous systemBrain Research, 1967